Urocortin 2 and urocortin 3 in endometriosis: evidence for a possible role in inflammatory response
Other
OA: bronze
CC0
⤵ 24 in-corpus citations
AI-generated summary
Urocortin 2 and 3 are expressed in endometriotic lesions and modulate inflammatory cytokine secretion from endometrial cells, suggesting a role in endometriosis pathogenesis.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Urocortin 2 (Ucn 2) and urocortin 3 (Ucn 3) are neuropeptides expressed by human endometrium. This study evaluated (i) the expression of Ucn 2 and Ucn 3 mRNA in endometriotic lesions and in endometrium of women with endometriosis; (ii) the effect of Ucn 2 and Ucn 3 on cytokines secretion from cultured endometrial stromal cells. Endometriotic tissue was collected from endometrioma (n=39); endometrial specimens were obtained from women with (n=39) and without (n=41) endometriosis throughout menstrual cycle. Tissue specimens were analysed for Ucn 2 and Ucn 3 mRNA expression and peptide localization; the effects of Ucn 2 or Ucn 3 on tumour necrosis factor (TNF-α) and interleukin (IL-4) secretion from cultured endometrial stromal cells was studied. Ucn 2 and Ucn 3 mRNA expression and localization were assessed by RT-PCR and by immuohistochemistry, respectively; cytokines secretion were measured by ELISA. Results showed that endometriotic tissue expressed both Ucn 2 and Ucn 3, with Ucn 3 expression higher in ectopic than in eutopic endometrium. Endometrial Ucn 2 mRNA expression in controls showed peak values at early proliferative phase, while in endometriotic patients low expression and no significant changes throughout menstrual cycle were observed. Endometrial Ucn 3 mRNA expression was highest in late secretory phase in controls, while in endometriotic patients low levels and no menstrual-cycle-related changes were found. When added to cultured endometrial cell cultures, Ucn 2 significantly increased TNF-α (P<0.01) and IL-4 (P<0.001), while Ucn 3 induced an increase of IL-4 secretion (P<0.01). In conclusion, endometriotic tissue expressed and localized Ucn 2 and Ucn 3; patients with endometriosis showed Ucn 2 and Ucn 3 mRNA expression in eutopic endometrium lower than in control group, with no endometrial cycle-related changes. Ucn 2 and Ucn 3-modulated TNF-α and IL-4 secretion from culture endometrial cells. These data suggest a possible involvement of Ucn 2 and Ucn 3 in the mechanisms of endometriosis.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (50)
- Clinical practice. Endometriosis via openalex
- Density of small diameter sensory nerve fibres in endometrium: a semi-invasive diagnostic test for minimal to mild endometriosis via openalex
- Endocrine regulation of menstruation via openalex
- Endometriosis via openalex
- Gene expression analysis of endometrium reveals progesterone resistance and candidate susceptibility genes in women with endometriosis via openalex
- Impaired CRH and urocortin expression and function in eutopic endometrium of women with endometriosis via openalex
- Increased numbers of activated mast cells in endometriosis lesions positive for corticotropin-releasing hormone and urocortin via openalex
- Interleukin-4 stimulates proliferation of endometriotic stromal cells via openalex
- Neuroendocrine cells in eutopic endometrium of women with endometriosis via openalex
- Overexpression and functional relevance of somatostatin receptor-1, -2, and -5 in endometrium and endometriotic lesions via openalex
- Plasma urocortin levels in the diagnosis of ovarian endometriosis via openalex
- W2042923816 via openalex
- W2044413542 via openalex
- W2048166634 via openalex
- W2048259893 via openalex
- W2048623914 via openalex
- W2051257264 via openalex
- W2008359430 via openalex
- W2004416362 via openalex
- W2075800748 via openalex
- W2075846272 via openalex
- W2083254635 via openalex
- W2085630652 via openalex
- W2088218868 via openalex
- W2088712700 via openalex
- W2090928145 via openalex
- W2091093168 via openalex
- W2093574478 via openalex
- W2096408525 via openalex
- W2099016831 via openalex
- W2101797636 via openalex
- W2104370010 via openalex
- W2107277218 via openalex
- W1989373932 via openalex
- W2110378157 via openalex
- W2123176887 via openalex
- W1978505781 via openalex
- W1974031271 via openalex
- W2133039069 via openalex
- W2141385349 via openalex
- W2144601716 via openalex
- W2152703367 via openalex
- W2156057711 via openalex
- W1896866869 via openalex
- W2204640292 via openalex
- W2477008945 via openalex
- W1807295484 via openalex
- W4231559875 via openalex
- W4248091259 via openalex
- W2023488387 via openalex
Cited by (26)
- Neuropeptides in endometriosis-associated pain: a review 2026
- The interaction between inflammation and estrogen in adenomyosis : from molecular mechanisms to therapeutic strategies 2026
- Urinary Urocortin as a Potential Non-Invasive Biomarker in Endometriosis: Exploratory Study with Histone H4 2025
- Screening and identification of key biomarkers associated with endometriosis using bioinformatics and next generation sequencing data analysis 2024
- Screening and identification of key biomarkers associated with endometriosis using bioinformatics and next-generation sequencing data analysis 2024
- Biomarkers of endometriosis 2023
- Possible Correlation between Urocortin 1 (Ucn1) and Immune Parameters in Patients with Endometriosis 2023
- Expression of HOXA10 Gene in Women with Endometriosis: A Systematic Review 2023
- The Role of Selected Chemokines in the Peritoneal Fluid of Women with Endometriosis—Participation in the Pathogenesis of the Disease 2021
- Endometriosis: New Perspective for the Diagnosis of Certain Cytokines in Women and Adolescent Girls, as Well as the Progression of Disease Outgrowth: A Systematic Review 2021
- Relationship Between Dairy Products Intake and Risk of Endometriosis: A Systematic Review and Dose-Response Meta-Analysis 2021
- The Link Between Stress and Endometriosis: from Animal Models to the Clinical Scenario 2020
- Current biomarkers for the detection of endometriosis 2020
- Diagnostic Performance of Neutrophil/Lymphocyte Ratio and Platelet/Lymphocyte Ratio in Endometrioma 2019
- Anti-inflammatory cytokines in endometriosis 2019
- Urocortin Expression in Endometriosis: A Systematic Review 2019
- The crosstalk between endometrial stromal cells and macrophages impairs cytotoxicity of NK cells in endometriosis by secreting IL-10 and TGF-β 2017
- Urocortin and corticotrophin-releasing hormone receptor type 2 mRNA are highly expressed in deep infiltrating endometriotic lesions 2016
- A new approach to the management of ovarian endometrioma to prevent tissue damage and recurrence 2016
- Serum markers for the noninvasive diagnosis of endometriosis 2015
- Molecular aspects of development and regulation of endometriosis 2014
- Endometriosis, a disease of the macrophage 2013
- Evaluation of mean platelet volume, neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in advanced stage endometriosis with endometrioma 2013
- Interplay between Misplaced Müllerian-Derived Stem Cells and Peritoneal Immune Dysregulation in the Pathogenesis of Endometriosis 2013
- Endometrioma: From Pathogenesis to Clinical Management 2013
- Evaluation of mean platelet volume, neutrophil/ lymphocyte ratio and platelet/lymphocyte ratio in advanced stage endometriosis with endometrioma Endometrioma bulunan ileri evre endometrioziste ortalama trombosit hacmi, nötrofil/lenfosit orani ve trombosit/lenfosit oraninin değerlendirilmesi 2013
Source provenance
- europepmc
- last seen: 2026-10-14T06:08:39.101224+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-10-08T21:08:47.456808+00:00
License: CC0
· commercial use OK